Cylite and QUT collaborate on early clinical validation of Cylite’s HP-OCT technology

Cylite and QUT collaborate

Cylite and QUT collaborate on early clinical validation of Cylite’s HP-OCT technology

Cylite today delivered the first unit of its Hyperparallel OCT platform to the Contact Lens and Visual Optics Laboratory in the Queensland University of Technology School of Optometry and Vision Science where Dr Emily Pieterse will lead QUTs clinical trial of Cylite’s unique Hyperparallel OCT technology.

Ready to redefine your perspective?

To find out how HP-OCT® can benefit you, your practice, and your patients, register your interest today.

Register your interest

Declaration

This website is intended for use by healthcare professionals only. By clicking agree, you are declaring that you are a registered healthcare professional with an appropriate registration.

If you do not agree, you’ll not be able to view the content on this page.